Extensior 1 mg Injection Combipack is a prescription injectable medicine containing Semaglutide 1 mg per dose. It is used alongside an appropriate diet and regular physical activity to improve blood-sugar control in adults with insufficiently controlled type 2 diabetes mellitus. Semaglutide belongs to a group of medicines known as glucagon-like peptide-1 receptor agonists, also called GLP-1 receptor agonists. It helps increase insulin release when blood glucose is elevated, reduces inappropriate glucagon secretion, and slows stomach emptying. Each pre-filled pen contains 4 mg of semaglutide in 3 mL and delivers 4 fixed 1 mg doses. The combipack contains one pre-filled pen and four disposable needles. The 1 mg strength is generally used after treatment with a lower semaglutide dose. It should not be used as the initial starting dose unless specifically directed by the prescribing healthcare professional.

Key Features

• Contains Semaglutide: A once-weekly GLP-1 receptor agonist.
• 1 mg Per Dose: Each injection delivers a fixed 1 mg dose of semaglutide.
• Four-Dose Pen: Each 3 mL pre-filled pen delivers four weekly doses.
• Supports Blood-Sugar Control: Helps reduce elevated blood-glucose levels in adults with type 2 diabetes.
• Once-Weekly Administration: Designed for use on the same day each week.
• Pre-Filled Pen: Allows accurate subcutaneous administration of the prescribed fixed dose.
• Prescription Medicine: Must be used according to a healthcare professional’s treatment plan.

Active Ingredient

• Semaglutide 1 mg per dose: A GLP-1 receptor agonist that supports glucose-dependent insulin release, reduces excess glucagon secretion, and slows gastric emptying.

Uses

• Improvement of blood-sugar control in adults with type 2 diabetes mellitus.
• Used together with an appropriate diet and regular physical activity.
• May be used alone when metformin is unsuitable due to intolerance or another medical reason.
• May be prescribed with other oral or injectable diabetes medicines when additional glucose control is required.
• Supports reduction of HbA1c as part of a medically supervised diabetes-management programme.

How to Use

• Use Extensior 1 mg Injection exactly as prescribed by your healthcare professional.
• Inject one prescribed dose once weekly, preferably on the same day each week.
• It may be administered at any time of the day, with or without meals.
• Inject it under the skin of the abdomen, thigh, or upper arm.
• Do not inject it into a vein or muscle.
• Rotate the injection site with every weekly dose.
• Attach a new compatible disposable needle before every injection.
• Turn the dose selector until the dose counter shows exactly 1 mg.
• Do not count pen clicks or attempt to select a partial dose.
• Press and hold the dose button until the dose counter returns to zero.
• Keep the needle under the skin and count slowly to six before removing it.
• Remove and safely discard the needle immediately after every injection.

Precautions

• Extensior 1 mg is not normally a starting dose and is generally reached after treatment with lower semaglutide strengths.
• It is not intended for type 1 diabetes or diabetic ketoacidosis and is not a substitute for insulin.
• Seek urgent medical attention for severe and persistent abdominal pain, particularly if accompanied by vomiting.
• Nausea, vomiting, and diarrhoea may cause dehydration and may affect kidney function.
• The risk of low blood sugar may increase when semaglutide is used with insulin or a sulfonylurea medicine.
• Report sudden or significant changes in vision promptly.
• Do not combine it with another semaglutide product or another GLP-1 receptor agonist unless specifically prescribed.
• Seek immediate medical assistance for facial swelling, breathing difficulty, severe rash, fainting, or another serious allergic reaction.

Possible Side Effects

• Nausea.
• Vomiting.
• Diarrhoea.
• Constipation.
• Abdominal pain or discomfort.
• Indigestion or acid reflux.
• Abdominal bloating or increased gas.
• Reduced appetite.
• Headache or dizziness.
• Fatigue.
• Injection-site redness, itching, or irritation.
• Low blood sugar when used with insulin or certain other diabetes medicines.
• Gallstones or gallbladder inflammation.

Storage

• Before first use, store the pen in a refrigerator between 2°C and 8°C.
• Keep it away from the refrigerator’s cooling element.
• Do not freeze or use a pen that has been frozen.
• Keep the pen cap attached to protect the medicine from light.
• After first use, the pen may be stored below 30°C or refrigerated between 2°C and 8°C for up to six weeks.
• Do not store the pen with a needle attached.
• Do not expose the pen to excessive heat or direct sunlight.
• Do not use the solution if it is cloudy, coloured, or contains visible particles.
• Discard the pen after the four prescribed doses have been used.
• Keep out of the sight and reach of children.

Legal Disclaimer: Extensior 1 mg Injection Combipack is a prescription semaglutide medicine intended for adults with type 2 diabetes mellitus. The 1 mg strength is generally used after gradual dose escalation. The dose, concurrent diabetes medicines, treatment duration, and continued use must be determined by a qualified healthcare professional. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, treatment, or the official patient leaflet and pen instructions.

The post Extensior 1mg Injection Combipack appeared first on PMC Herbals.

Obesema 2.4 mg Injection is a prescription pre-filled injection pen containing Semaglutide 2.4 mg per dose. It is used together with a reduced-calorie diet and increased physical activity to support chronic weight management in eligible adults. Semaglutide belongs to a group of medicines known as glucagon-like peptide-1 receptor agonists, also called GLP-1 receptor agonists. It helps regulate appetite, reduce hunger, increase feelings of fullness, and support lower food intake. Each multidose disposable pen contains 9.6 mg of semaglutide in 3 mL and provides four fixed doses of 2.4 mg. The 2.4 mg strength is generally used as a maintenance dose after gradual dose escalation and should not be used as the initial treatment dose.

Key Features

• Contains Semaglutide: A once-weekly GLP-1 receptor agonist.
• 2.4 mg Per Dose: Each prescribed injection delivers 2.4 mg of semaglutide.
• Four-Dose Pen: Each multidose disposable pen provides four weekly doses.
• Supports Weight Management: Helps regulate appetite and reduce calorie intake.
• Once-Weekly Administration: Designed for use on the same day each week.
• Subcutaneous Injection: Administered under the skin of the abdomen, thigh, or upper arm.
• Maintenance Strength: The 2.4 mg dose is reached only after gradual dose escalation.

Active Ingredient

• Semaglutide 2.4 mg per dose

Uses

• Chronic weight management in eligible adults with obesity.
• Supporting weight loss when combined with a reduced-calorie diet and increased physical activity.
• Supporting long-term maintenance of reduced body weight under medical supervision.

How to Use

• Inject one prescribed dose once weekly on the same day each week.
• It may be administered at any time of the day, with or without food.
• Inject it under the skin of the abdomen, thigh, or upper arm.
• Do not inject it into a vein or muscle.
• Rotate the injection site with every weekly dose.
• Attach a new compatible needle before each injection.
• Check that the solution is clear and colourless before use.
• Remove and safely discard the needle immediately after every injection.

Precautions

• Obesema 2.4 mg is a maintenance strength and should be reached only through the prescribed dose-escalation schedule.
• Nausea, vomiting, and diarrhoea may cause dehydration. Maintain adequate fluid intake unless medically restricted.
• The risk of low blood sugar may increase when semaglutide is used with insulin or sulfonylurea medicines.
• People with diabetes should promptly report sudden or worsening changes in vision.
• Inform healthcare professionals that you use semaglutide before surgery, general anaesthesia, or deep sedation.
• Do not combine it with another semaglutide medicine or GLP-1 receptor agonist unless specifically directed
• Seek immediate medical assistance for facial swelling, breathing difficulty, fainting, or another serious allergic reaction.

Possible Side Effects

• Nausea.
• Vomiting.
• Diarrhoea.
• Constipation.
• Abdominal pain or discomfort.
• Indigestion or heartburn.
• Abdominal bloating or increased gas.
• Headache.
• Dizziness.
• Fatigue.
• Injection-site redness, itching, or irritation.
• Low blood sugar when used with certain diabetes medicines.
• Gallstones or gallbladder inflammation.

Storage

• Before first use, store the pen in a refrigerator between 2°C and 8°C.
• Do not freeze or use a pen that has been frozen.
• Keep the pen away from the refrigerator’s cooling element.
• Keep it in its original packaging to protect it from light.
• Keep the pen cap attached when the pen is not being used.
• Do not store the pen with a needle attached.
• Keep out of the sight and reach of children.

Legal Disclaimer: Obesema 2.4 mg Injection is a prescription semaglutide medicine and a maintenance-dose strength. It should be used only after gradual dose escalation and under the supervision of a qualified healthcare professional. The prescribing doctor must determine eligibility, dose selection, treatment duration, and continued use. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, treatment, or the original instructions supplied with the medicine.

The post Obesema 2.4mg Injection appeared first on PMC Herbals.

Obesema 0.5 mg Injection is a prescription pre-filled injection pen containing Semaglutide 0.5 mg per dose. It is used with a reduced-calorie diet and regular physical activity to support long-term weight management in eligible adults. Semaglutide belongs to a group of medicines known as glucagon-like peptide-1 receptor agonists, also called GLP-1 receptor agonists. It acts on areas involved in appetite regulation, helping reduce hunger, increase feelings of fullness, and support reduced calorie intake. Each multidose disposable pen provides four doses of 0.5 mg for once-weekly administration. The 0.5 mg strength is generally used after an initial lower-dose treatment period and should be started only according to the prescribing healthcare professional’s dose-escalation plan.

Key Features

• Contains Semaglutide: A once-weekly GLP-1 receptor agonist.
• 0.5 mg Per Dose: Each prescribed injection delivers 0.5 mg of semaglutide.
• Four-Dose Pen: Each multidose disposable pen provides four weekly doses.
• Supports Weight Management: Helps regulate appetite and reduce calorie intake.
• Once-Weekly Administration: Designed for use on the same day each week.
• Subcutaneous Injection: Administered under the skin of the abdomen, thigh, or upper arm.
• Prescription Medicine: Must be used as part of a medically supervised treatment programme.

Active Ingredient

• Semaglutide 0.5 mg per dose: A GLP-1 receptor agonist that helps regulate appetite, increase fullness, and reduce food intake.

Uses

• Long-term weight management in eligible adults with obesity.
• Weight management in eligible overweight adults who have at least one weight-related health condition.
• Weight-loss maintenance when combined with a reduced-calorie diet and increased physical activity.
• Reduction of cardiovascular risk in selected adults with established cardiovascular disease and obesity or overweight, when specifically prescribed.

How to Use

• Use Obesema 0.5 mg Injection exactly as prescribed by your healthcare professional.
• Inject the prescribed dose once weekly on the same day each week.
• It may generally be administered at any time of day, with or without food.
• Inject it under the skin of the abdomen, thigh, or upper arm.
• Do not inject it into a vein or muscle.
• Rotate the injection site with each weekly dose.
• Use a new compatible needle for every injection.

Precautions

• Obesema 0.5 mg is generally a dose-escalation strength and is not normally the first treatment dose.
• Nausea, vomiting, and diarrhoea may cause dehydration. Maintain adequate fluid intake unless medically restricted.
• The risk of low blood sugar may increase when semaglutide is used with insulin or sulfonylurea medicines.
• People with diabetes should report sudden or worsening changes in vision.

Possible Side Effects

• Nausea.
• Vomiting.
• Diarrhoea.
• Constipation.
• Abdominal pain or discomfort.
• Indigestion or heartburn.
• Abdominal bloating or increased gas.
• Headache.
• Dizziness.
• Fatigue.
• Injection-site redness, itching, or irritation.
• Low blood sugar when used with certain diabetes medicines.
• Gallstones or gallbladder inflammation.

Storage

• Store the unused pen in a refrigerator between 2°C and 8°C.
• Do not freeze or use a pen that has been frozen.
• Keep the pen away from the refrigerator’s cooling element.
• Keep the pen in its original packaging to protect it from light.
• Do not store the pen with a needle attached.
• Follow the original Obesema pack instructions for storage after first use and the permitted in-use period.
• Do not use if the solution appears cloudy, coloured, or contains visible particles.
• Do not use if the pen, seal, or packaging is damaged or tampered with.
• Keep out of the sight and reach of children.

Legal Disclaimer: Obesema 0.5 mg Injection is a prescription semaglutide medicine intended for use under the supervision of a qualified healthcare professional. The prescribing doctor must determine eligibility, dose escalation, treatment duration, and continued use. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, treatment, or the original instructions supplied with the medicine.

The post Obesema 0.5mg Injection appeared first on PMC Herbals.

Wegovy 2.4mg FlexTouch contains Semaglutide 2.4 mg per dose, a prescription injectable medicine used under medical supervision for chronic weight management in eligible patients. It is used along with a reduced-calorie diet, increased physical activity, and lifestyle changes as advised by a healthcare professional. Semaglutide belongs to a class of medicines known as GLP-1 receptor agonists. It works by acting on appetite-regulating pathways, helping reduce hunger, improve fullness, and support long-term weight-management efforts when used as part of a doctor-directed plan. Wegovy 2.4mg FlexTouch is generally used as a maintenance dose after gradual dose escalation. It is designed for once-weekly subcutaneous injection. Each pre-filled pen contains 4 doses, with each dose delivering 2.4 mg/0.75 mL.

Key Features

• Contains Semaglutide 2.4 mg: A GLP-1 receptor agonist used for doctor-supervised weight management.
• Maintenance Dose Strength: Commonly used after step-wise dose escalation as advised by the doctor.
• FlexTouch Pre-Filled Pen: Designed for convenient subcutaneous injection as prescribed.
• Once-Weekly Use: Administered once every week on the same day, as directed by a healthcare professional.
• Prescription-Only Medicine: Should be used only under medical supervision.

Active Ingredient

• Semaglutide 2.4 mg per dose: A GLP-1 receptor agonist used to support chronic weight management in eligible patients under healthcare professional guidance.

How to Use

• Use Wegovy 2.4mg FlexTouch exactly as prescribed by your doctor.
• Inject once weekly under the skin, usually in the abdomen, thigh, or upper arm as advised.
• Do not inject into a vein or muscle.
• Use it on the same day each week for better routine adherence.
• Rotate injection sites to reduce the risk of skin irritation or lumps.
• Use a new needle for each injection if required by the device instructions.
• Do not share your pen or needles with anyone.
• Do not change the dose or stop using this medicine without consulting your healthcare provider.

Precautions

• Use only under the supervision of a qualified healthcare professional.
• Inform your doctor if you have pancreas problems, kidney disease, gallbladder disease, stomach emptying problems, diabetic eye disease, or any serious medical condition.
• Tell your doctor if you are pregnant, planning a pregnancy, or breastfeeding.
• Inform your healthcare provider about all prescription medicines, OTC products, vitamins, and supplements you are using.
• Follow the diet and physical activity plan recommended by your doctor.
• This medicine should not be used as a quick or cosmetic weight-loss product.

Warning

• Possible side effects may include nausea, vomiting, diarrhea, constipation, stomach pain, headache, tiredness, indigestion, bloating, reduced appetite, or injection-site reactions.
• Seek medical help immediately if you experience severe abdominal pain, persistent vomiting, dehydration, allergic reaction, swelling, breathing difficulty, or signs of pancreatitis.
• Do not use this medicine if you are allergic to semaglutide or any ingredient in the injection.
• Risk of low blood sugar may increase if used with insulin or sulfonylurea medicines in patients with diabetes.
• Use only as directed by your healthcare provider.

Storage

• Store in a refrigerator as directed on the product label.
• Do not freeze the pen.
• Protect from direct sunlight and excessive heat.
• Keep the pen cap on when not in use.
• Do not use if the solution appears cloudy, discolored, frozen, or contains particles.
• Keep out of reach of children and pets.

Legal Disclaimer: Wegovy 2.4mg FlexTouch is a prescription injectable medicine and should be used only under the supervision of a qualified healthcare professional. This information is provided for educational and product information purposes only and should not replace professional medical advice, diagnosis, or treatment. Always follow your doctor’s instructions before using this medicine.

The post Wegovy 2.4mg FlexTouch appeared first on PMC Herbals.

Wegovy 0.5mg FlexTouch contains Semaglutide 0.5 mg per dose, a prescription injectable medicine used under medical supervision for chronic weight management in eligible adults and adolescents, along with a reduced-calorie diet, increased physical activity, and lifestyle management as advised by a healthcare professional. Semaglutide belongs to a class of medicines known as GLP-1 receptor agonists. It works by acting on appetite-regulating pathways, helping reduce hunger, increase fullness, and support better weight-control efforts when used as part of a doctor-directed treatment plan. Wegovy 0.5mg FlexTouch is designed for once-weekly subcutaneous injection. It is usually used as part of a step-up dosing schedule, where the dose may be increased gradually depending on the doctor’s advice and the patient’s tolerance.

Key Features

• Contains Semaglutide 0.5 mg: A GLP-1 receptor agonist used for doctor-supervised weight management.
• FlexTouch Pre-Filled Pen: Designed for convenient subcutaneous injection as prescribed.
• Once-Weekly Use: Administered once every week on the same day, as advised by the doctor.
• Supports Appetite Control: Helps reduce hunger and increase fullness when combined with diet and activity changes.
• Prescription-Only Medicine: Should be used only under medical supervision.

Active Ingredient

• Semaglutide 0.5 mg per dose: A GLP-1 receptor agonist used to support chronic weight management in eligible patients under healthcare professional guidance.

How to Use

• Use Wegovy 0.5mg FlexTouch exactly as prescribed by your doctor.
• Inject once weekly under the skin, usually in the abdomen, thigh, or upper arm as advised.
• Do not inject into a vein or muscle.
• Use it on the same day each week for better routine adherence.
• Rotate injection sites to reduce the risk of skin irritation or lumps.
• Use a new needle for each injection if required by the device instructions.
• Do not share your pen or needles with anyone.
• Do not change the dose or stop using this medicine without consulting your healthcare provider.

Precautions

• Use only under the supervision of a qualified healthcare professional.
• Inform your doctor if you have pancreas problems, kidney disease, gallbladder disease, stomach emptying problems, diabetic eye disease, or any serious medical condition.
• Tell your doctor if you are pregnant, planning a pregnancy, or breastfeeding.
• Inform your healthcare provider about all prescription medicines, OTC products, vitamins, and supplements you are using.
• Follow the diet and physical activity plan recommended by your doctor.
• This medicine should not be used as a quick or cosmetic weight-loss product.

Warning

• Possible side effects may include nausea, vomiting, diarrhea, constipation, stomach pain, headache, tiredness, indigestion, bloating, reduced appetite, or injection-site reactions.
• Seek medical help immediately if you experience severe abdominal pain, persistent vomiting, dehydration, allergic reaction, swelling, breathing difficulty, or signs of pancreatitis.
• Do not use this medicine if you are allergic to semaglutide or any ingredient in the injection.
• Risk of low blood sugar may increase if used with insulin or sulfonylurea medicines in patients with diabetes.
• Use only as directed by your healthcare provider.

Storage

• Store in a refrigerator as directed on the product label.
• Do not freeze the pen.
• Protect from direct sunlight and excessive heat.
• Keep the pen cap on when not in use.
• Do not use if the solution appears cloudy, discolored, frozen, or contains particles.
• Keep out of reach of children and pets.

Legal Disclaimer: Wegovy 0.5mg FlexTouch is a prescription injectable medicine and should be used only under the supervision of a qualified healthcare professional. This information is provided for educational and product information purposes only and should not replace professional medical advice, diagnosis, or treatment. Always follow your doctor’s instructions before using this medicine.

The post Wegovy 0.5mg FlexTouch appeared first on PMC Herbals.

Sembolic 7mg Tablet contains Semaglutide 7mg, an oral prescription medicine used under medical supervision to help improve blood sugar control in adults with type 2 diabetes mellitus. It is generally used along with a proper diet, exercise plan, and other lifestyle measures as advised by a healthcare professional. Semaglutide belongs to a class of medicines known as GLP-1 receptor agonists. It works by helping the body release insulin when blood sugar levels are high, reducing excess sugar release from the liver, and slowing stomach emptying. These actions help support better blood glucose management when the medicine is taken correctly. Sembolic 7 mg tablet should be taken only as prescribed by your doctor. The dose and duration depend on blood sugar levels, treatment history, medical condition, and response to therapy.

Key Features

• Contains Semaglutide 7mg: A GLP-1 receptor agonist used for type 2 diabetes management.
• Helps Improve Blood Sugar Control: Supports glycemic control when used with diet and exercise.
• Oral Tablet Form: Convenient tablet form for once-daily use as prescribed.
• Doctor-Directed Diabetes Care: Used as part of a structured diabetes management plan.
• Prescription-Only Medicine: Should be used only under medical supervision.

Active Ingredient

• Semaglutide 7mg: A GLP-1 receptor agonist that helps support blood sugar control in adults with type 2 diabetes mellitus.

How to Use

• Take Sembolic 7 mg tablet exactly as prescribed by your doctor.
• Take the tablet on an empty stomach, preferably after waking up.
• Swallow the tablet whole with a small amount of plain water.
• Do not crush, chew, split, or break the tablet.
• Wait at least 30 minutes before eating, drinking, or taking other oral medicines, unless advised differently by your doctor.
• Take it at the same time each day for better routine adherence.
• Do not stop or change the dose without consulting your healthcare provider.

Precautions

• Use only under the supervision of a qualified healthcare professional.
• Inform your doctor if you have pancreas problems, kidney disease, stomach or digestive disorders, or any serious medical condition.
• Tell your doctor if you are pregnant, planning a pregnancy, or breastfeeding.
• Inform your healthcare provider about all diabetes medicines, prescription medicines, OTC products, vitamins, and supplements you are using.
• Monitor blood sugar levels regularly as advised by your doctor.
• This medicine is not intended for type 1 diabetes or diabetic ketoacidosis.

Warning

• Possible side effects may include nausea, vomiting, diarrhea, constipation, stomach pain, reduced appetite, indigestion, or bloating.
• Consult your doctor immediately if you experience severe abdominal pain, persistent vomiting, dehydration, or signs of low blood sugar.
• Do not use this medicine if you are allergic to semaglutide or any ingredient in the tablet.
• Do not use more than the prescribed dose.
• This medicine should not be used as a cosmetic weight-loss product.
• Use only as directed by your healthcare provider.

Storage

• Store in a cool and dry place.
• Protect from direct sunlight, heat, and moisture.
• Keep the tablets in their original packaging until use.
• Keep out of reach of children and pets.

Legal Disclaimer: Sembolic 7mg Tablet is a prescription medicine and should be used only under the supervision of a qualified healthcare professional. This information is provided for educational and product information purposes only and should not replace professional medical advice, diagnosis, or treatment. Always follow your doctor’s instructions before using this medicine.

The post Sembolic 7mg Semaglutide Oral Tablets appeared first on PMC Herbals.

Sembolic Injection contains Semaglutide and is a prescription medication supplied in an injectable form. It is designed for administration under the guidance of a qualified healthcare professional. The injection is intended for long-term treatment plans as prescribed by a physician and should be used according to the recommended dosing schedule. Regular medical follow-ups and adherence to the prescribed treatment plan are important for optimal use.

Key Features

• Contains Semaglutide as the active ingredient.
• Convenient once-weekly administration as directed by a healthcare professional.
• Pre-measured injectable formulation for prescribed use.
• Suitable for use as part of a physician-directed treatment plan.
• Designed for long-term supervised therapy.
• Easy-to-follow dosing schedule when used as prescribed.

Key Ingredients

• Semaglutide – Active pharmaceutical ingredient.

How to Use

• Use only under the supervision of a qualified healthcare professional.
• Administer exactly as prescribed by your doctor.
• Follow the recommended dosing schedule.
• Do not exceed the prescribed dose.
• Read all instructions provided with the product before use.
• Consult your healthcare provider for proper administration guidance.

Storage Information

• Store in a refrigerator between 2°C and 8°C unless otherwise directed on the packaging.
• Do not freeze.
• Protect from direct sunlight and excessive heat.
• Keep the product in its original packaging until use.
• Keep out of reach of children.

Precautions

• For prescription use only.
• Inform your healthcare provider about any existing medical conditions before use.
• Discuss all medications and supplements you are taking with your doctor.
• Do not use the product if the packaging is damaged or tampered with.
• Use only as directed by a healthcare professional.

Legal Disclaimer: The product is guaranteed to be 100% genuine. Product images are for illustrative purposes only. Images/packaging/labels may vary from time to time due to changes made by the manufacturer’s manufacturing batch and location. The product description is for information purposes only and may contain additional ingredients. This product is a prescription medication and should be used only under the supervision of a qualified healthcare professional.

The post Sembolic Injection for Weight Loss appeared first on PMC Herbals.

Derise 100 Pre-filled Syringe contains Darbepoetin Alfa, a synthetic erythropoiesis-stimulating agent (ESA) used to treat anemia associated with chronic kidney disease, chemotherapy, and certain other medical conditions. It works by stimulating the bone marrow to produce more red blood cells, helping improve hemoglobin levels and reduce symptoms of anemia such as fatigue, weakness, and shortness of breath. The pre-filled syringe is designed for accurate and convenient administration. By increasing red blood cell production, Derise 100 helps improve oxygen delivery throughout the body, supporting overall energy levels and quality of life in patients with anemia. Derise 100 Pre-filled Syringe should be used under the supervision of a qualified healthcare professional, with regular monitoring of hemoglobin levels and other relevant laboratory parameters.

Key Features

• Helps Manage Anemia: Supports the treatment of anemia caused by chronic kidney disease or chemotherapy.
• Stimulates Red Blood Cell Production: Encourages the bone marrow to produce more red blood cells.
• Improves Hemoglobin Levels: Helps maintain healthy oxygen-carrying capacity in the blood.
• Pre-filled Syringe: Convenient and accurate dosing for administration.
• Supports Energy & Well-Being: Helps reduce symptoms associated with anemia.

Key Ingredient

• Darbepoetin Alfa: An erythropoiesis-stimulating agent that promotes red blood cell production.

How to Use

• Use exactly as prescribed by your healthcare professional.
• Administer by subcutaneous or intravenous injection as directed.
• Do not shake the syringe before use.
• Inspect the solution before administration; do not use if discolored or containing particles.
• Follow the prescribed dosing schedule carefully.

Precautions

• Use only under medical supervision.
• Regular monitoring of hemoglobin levels is required during treatment.
• Inform your doctor about any history of hypertension, heart disease, or blood clotting disorders.
• Store refrigerated at 2°C–8°C and protect from light.
• Do not freeze the syringe.

Warning

• May increase the risk of high blood pressure, blood clots, heart attack, or stroke in some patients.
• Seek immediate medical attention if symptoms of a serious allergic reaction occur.
• Do not use without proper medical monitoring.
• Keep out of reach of children.

Legal Disclaimer: Derise 100 Pre-filled Syringe is a prescription medication intended for the treatment of anemia in specific medical conditions. Use only under the supervision of a qualified healthcare professional. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

The post Derise 100 Pre-filled Syringe appeared first on PMC Herbals.

Basaglar KwikPen Solution for Injection contains Insulin Glargine 100 IU/ml, a long-acting insulin analog used to improve blood sugar control in adults and children with diabetes mellitus. It provides a steady release of insulin over an extended period, helping maintain consistent blood glucose levels throughout the day and night. The pre-filled KwikPen is designed for convenient and accurate insulin administration. It delivers insulin through subcutaneous injection and is commonly used as a basal insulin as part of a comprehensive diabetes management plan that includes proper diet, exercise, and regular blood glucose monitoring. Basaglar helps support long-term blood sugar control and may be prescribed alone or in combination with other antidiabetic medications as directed by a healthcare professional.

Key Features

• Long-Acting Insulin: Provides continuous blood glucose control for up to 24 hours.
• Pre-Filled KwikPen: Easy-to-use device for accurate dose administration.
• Supports Diabetes Management: Helps maintain stable blood sugar levels.
• Once-Daily Dosing: Typically administered once daily as prescribed.
• Suitable for Type 1 & Type 2 Diabetes: Used in adults and eligible pediatric patients.

Key Ingredient

• Insulin Glargine 100 IU/ml: A long-acting insulin analog that helps regulate blood glucose levels.

How to Use

• Use exactly as prescribed by your healthcare professional.
• Administer as a subcutaneous injection in the abdomen, thigh, or upper arm.
• Rotate injection sites to reduce the risk of skin-related complications.
• Check the insulin solution before use; it should be clear and colorless.
• Use a new needle for each injection.
• Monitor blood glucose levels regularly as advised.

Precautions

• Use only under medical supervision.
• Do not inject into a vein or muscle.
• Do not share the pen device with others.
• Store unopened pens in a refrigerator at 2°C–8°C.
• Do not freeze the product.
• Inform your doctor about any kidney, liver, or heart conditions.

Warning

• May cause hypoglycemia (low blood sugar), which can be serious.
• Common side effects may include injection site reactions, itching, rash, swelling, and weight gain.
• Seek immediate medical attention if severe allergic reactions occur.
• Keep out of reach of children.

Legal Disclaimer: Basaglar KwikPen Solution for Injection (3ml Pre-Filled Pen) is a prescription medication intended for the management of diabetes mellitus. Use only under the guidance of a qualified healthcare professional. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

The post Basaglar Kwikpen Solution for Injection (3ml pre-filled pen) appeared first on PMC Herbals.

Trulicity 0.75mg Pre-Filled Pen contains Dulaglutide 0.75mg, a GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes mellitus. It works by stimulating insulin release when blood sugar levels are elevated, reducing glucose production by the liver, and slowing gastric emptying to help maintain better glycemic control.

The pre-filled pen is designed for simple and convenient once-weekly administration, allowing patients to manage their treatment with ease. When combined with a healthy diet and regular exercise, Trulicity helps support long-term blood glucose management and may help reduce the risk of diabetes-related complications.

The ready-to-use pen delivers an accurate dose without the need for mixing or measuring, making it a practical option for individuals requiring ongoing diabetes care under medical supervision.

Key Features

• Once-Weekly Dosing: Convenient injection schedule for improved treatment adherence.
• Helps Lower Blood Sugar: Supports effective glycemic control in adults with type 2 diabetes.
• Pre-Filled Pen Device: Ready-to-use design for easy and accurate administration.
• Supports Comprehensive Diabetes Management: Works alongside diet and exercise programs.
• User-Friendly Design: Simplifies self-administration with minimal preparation.

Key Ingredient

• Dulaglutide 0.75mg: A GLP-1 receptor agonist that helps regulate blood glucose levels.

How to Use

• Use exactly as prescribed by your healthcare professional.
• Administer as a subcutaneous injection once weekly.
• Inject into the abdomen, thigh, or upper arm.
• Use on the same day each week whenever possible.
• Follow the instructions supplied with the pen device.
• Do not change the dosage without medical advice.

Precautions

• Use only under medical supervision.
• Inform your doctor about any history of pancreatitis, kidney disease, or gastrointestinal disorders.
• Monitor blood glucose levels regularly as advised.
• Store refrigerated at 2°C–8°C and do not freeze.
• Keep the pen protected from direct light and excessive heat.

Warning

• Common side effects may include nausea, vomiting, diarrhea, abdominal discomfort, and reduced appetite.
• Seek immediate medical attention if symptoms of pancreatitis occur.
• May increase the risk of hypoglycemia when used with other diabetes medications.
• Keep out of reach of children.

Legal Disclaimer: Trulicity 0.75mg Pre-Filled Pen is a prescription medication intended for the management of type 2 diabetes mellitus. Use only under the supervision of a qualified healthcare professional. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

The post Trulicity 0.75mg Pre-Filled Pen appeared first on PMC Herbals.